ArticleInternational journal of general medicine2022

Influence of KDR Genetic Variation on the Effectiveness and Safety of Bevacizumab in the First-Line Treatment for Patients with Advanced Colorectal Cancer.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.